NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases

Biomol Ther (Seoul). 2023 Jul 1;31(4):395-401. doi: 10.4062/biomolther.2023.099.

Abstract

Innate immunity is a first line defence system in the body which is for sensing signals of danger such as pathogenic microbes or host-derived signals of cellular stress. Pattern recognition receptors (PRR's), which present in the cell memebrane, are suspect the infection through pathogen-associated molecular patterns (PAMP), and activate innate immunity with response to promote inflammation via inflammatory cells such as macrophages and neutrophils, and cytokines. Inflammasome are protein complexes which are part of innate immunity in inflammation to remove pathogens and repair damaged tissues. What is the important role of inflammation in disease? In this review, we are focused on the action mechanism of NLRP3 inflammasome in inflammatory diseases such as asthma, atopic dermatitis, and sepsis.

Keywords: Asthma; Atopic dermatitis; Inflammasome; Sepsis.

Publication types

  • Review

Grants and funding

ACKNOWLEDGMENTS This paper was supported by the Academic Research Fund of Dr. Myung Ki (MIKE) Hong in 2021.